nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00275	0.00275	CcSEcCtD
Zanamivir—Malaise—Irinotecan—pancreatic cancer	0.00274	0.00274	CcSEcCtD
Zanamivir—Syncope—Irinotecan—pancreatic cancer	0.00273	0.00273	CcSEcCtD
Zanamivir—Dyspnoea—Sunitinib—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Loss of consciousness—Irinotecan—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Zanamivir—Malaise—Gemcitabine—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00267	0.00267	CcSEcCtD
Zanamivir—Cough—Irinotecan—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Zanamivir—Decreased appetite—Sunitinib—pancreatic cancer	0.00262	0.00262	CcSEcCtD
Zanamivir—Fatigue—Sunitinib—pancreatic cancer	0.0026	0.0026	CcSEcCtD
Zanamivir—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Cough—Gemcitabine—pancreatic cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Pain—Sunitinib—pancreatic cancer	0.00258	0.00258	CcSEcCtD
Zanamivir—Discomfort—Irinotecan—pancreatic cancer	0.00256	0.00256	CcSEcCtD
Zanamivir—Asthenia—Tamoxifen—pancreatic cancer	0.00253	0.00253	CcSEcCtD
Zanamivir—Convulsion—Fluorouracil—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Zanamivir—Arthralgia—Gemcitabine—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Zanamivir—Myalgia—Gemcitabine—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Zanamivir—Increased appetite—Epirubicin—pancreatic cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Confusional state—Irinotecan—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Asthenia—Erlotinib—pancreatic cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Discomfort—Gemcitabine—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Zanamivir—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Myalgia—Fluorouracil—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Infection—Irinotecan—pancreatic cancer	0.00247	0.00247	CcSEcCtD
Zanamivir—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Discomfort—Fluorouracil—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Zanamivir—Shock—Irinotecan—pancreatic cancer	0.00244	0.00244	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Zanamivir—Haemoglobin—Docetaxel—pancreatic cancer	0.00243	0.00243	CcSEcCtD
Zanamivir—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Zanamivir—Haemorrhage—Docetaxel—pancreatic cancer	0.00242	0.00242	CcSEcCtD
Zanamivir—Diarrhoea—Tamoxifen—pancreatic cancer	0.00241	0.00241	CcSEcCtD
Zanamivir—Infection—Gemcitabine—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Zanamivir—Confusional state—Fluorouracil—pancreatic cancer	0.0024	0.0024	CcSEcCtD
Zanamivir—Abdominal pain—Sunitinib—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Zanamivir—Body temperature increased—Sunitinib—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Zanamivir—Diarrhoea—Erlotinib—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Zanamivir—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00238	0.00238	CcSEcCtD
Zanamivir—Anorexia—Irinotecan—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Zanamivir—Infection—Fluorouracil—pancreatic cancer	0.00236	0.00236	CcSEcCtD
Zanamivir—Skin disorder—Gemcitabine—pancreatic cancer	0.00235	0.00235	CcSEcCtD
Zanamivir—Dizziness—Tamoxifen—pancreatic cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Increased appetite—Doxorubicin—pancreatic cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Anorexia—Gemcitabine—pancreatic cancer	0.00231	0.00231	CcSEcCtD
Zanamivir—Dizziness—Erlotinib—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Zanamivir—Erythema multiforme—Docetaxel—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Zanamivir—Face oedema—Epirubicin—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Anorexia—Fluorouracil—pancreatic cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Zanamivir—Vomiting—Tamoxifen—pancreatic cancer	0.00224	0.00224	CcSEcCtD
Zanamivir—Hypersensitivity—Sunitinib—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Zanamivir—Rash—Tamoxifen—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Zanamivir—Dermatitis—Tamoxifen—pancreatic cancer	0.00222	0.00222	CcSEcCtD
Zanamivir—Vomiting—Erlotinib—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Dyspnoea—Irinotecan—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Zanamivir—Headache—Tamoxifen—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Zanamivir—Rash—Erlotinib—pancreatic cancer	0.0022	0.0022	CcSEcCtD
Zanamivir—Dermatitis—Erlotinib—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Zanamivir—Dehydration—Epirubicin—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Zanamivir—Headache—Erlotinib—pancreatic cancer	0.00218	0.00218	CcSEcCtD
Zanamivir—Chills—Docetaxel—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Zanamivir—Asthenia—Sunitinib—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Decreased appetite—Irinotecan—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Arrhythmia—Docetaxel—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Dyspnoea—Gemcitabine—pancreatic cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Fatigue—Irinotecan—pancreatic cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Pain—Irinotecan—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Dyspnoea—Fluorouracil—pancreatic cancer	0.00212	0.00212	CcSEcCtD
Zanamivir—Face oedema—Doxorubicin—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Zanamivir—Decreased appetite—Gemcitabine—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Zanamivir—Nausea—Tamoxifen—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Zanamivir—Fatigue—Gemcitabine—pancreatic cancer	0.00209	0.00209	CcSEcCtD
Zanamivir—Pain—Gemcitabine—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Zanamivir—Nausea—Erlotinib—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Zanamivir—Decreased appetite—Fluorouracil—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Zanamivir—Diarrhoea—Sunitinib—pancreatic cancer	0.00206	0.00206	CcSEcCtD
Zanamivir—Feeling abnormal—Irinotecan—pancreatic cancer	0.00205	0.00205	CcSEcCtD
Zanamivir—Asthma—Epirubicin—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Zanamivir—Influenza—Epirubicin—pancreatic cancer	0.00204	0.00204	CcSEcCtD
Zanamivir—Pain—Fluorouracil—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Zanamivir—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Zanamivir—Dehydration—Doxorubicin—pancreatic cancer	0.00203	0.00203	CcSEcCtD
Zanamivir—Dizziness—Sunitinib—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Abdominal pain—Irinotecan—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Body temperature increased—Irinotecan—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Bronchitis—Epirubicin—pancreatic cancer	0.00196	0.00196	CcSEcCtD
Zanamivir—Vomiting—Sunitinib—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Zanamivir—Body temperature increased—Gemcitabine—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Zanamivir—Neutropenia—Epirubicin—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Zanamivir—Rash—Sunitinib—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Zanamivir—Dermatitis—Sunitinib—pancreatic cancer	0.0019	0.0019	CcSEcCtD
Zanamivir—Urticaria—Fluorouracil—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Zanamivir—Headache—Sunitinib—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Zanamivir—Syncope—Docetaxel—pancreatic cancer	0.00189	0.00189	CcSEcCtD
Zanamivir—Influenza—Doxorubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Zanamivir—Asthma—Doxorubicin—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Zanamivir—Body temperature increased—Fluorouracil—pancreatic cancer	0.00188	0.00188	CcSEcCtD
Zanamivir—Loss of consciousness—Docetaxel—pancreatic cancer	0.00185	0.00185	CcSEcCtD
Zanamivir—Cough—Docetaxel—pancreatic cancer	0.00184	0.00184	CcSEcCtD
Zanamivir—Hypersensitivity—Irinotecan—pancreatic cancer	0.00183	0.00183	CcSEcCtD
Zanamivir—Convulsion—Docetaxel—pancreatic cancer	0.00182	0.00182	CcSEcCtD
Zanamivir—Bronchitis—Doxorubicin—pancreatic cancer	0.00181	0.00181	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.0018	0.0018	CcSEcCtD
Zanamivir—Myalgia—Docetaxel—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Zanamivir—Arthralgia—Docetaxel—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Zanamivir—Nausea—Sunitinib—pancreatic cancer	0.00179	0.00179	CcSEcCtD
Zanamivir—Asthenia—Irinotecan—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Zanamivir—Neutropenia—Doxorubicin—pancreatic cancer	0.00176	0.00176	CcSEcCtD
Zanamivir—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00175	0.00175	CcSEcCtD
Zanamivir—Asthenia—Gemcitabine—pancreatic cancer	0.00174	0.00174	CcSEcCtD
Zanamivir—Confusional state—Docetaxel—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Zanamivir—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00172	0.00172	CcSEcCtD
Zanamivir—Infection—Docetaxel—pancreatic cancer	0.00171	0.00171	CcSEcCtD
Zanamivir—Sinusitis—Epirubicin—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Zanamivir—Diarrhoea—Irinotecan—pancreatic cancer	0.0017	0.0017	CcSEcCtD
Zanamivir—Shock—Docetaxel—pancreatic cancer	0.00169	0.00169	CcSEcCtD
Zanamivir—Skin disorder—Docetaxel—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00167	0.00167	CcSEcCtD
Zanamivir—Diarrhoea—Gemcitabine—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Zanamivir—Dizziness—Irinotecan—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Zanamivir—Haemoglobin—Epirubicin—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Zanamivir—Anorexia—Docetaxel—pancreatic cancer	0.00164	0.00164	CcSEcCtD
Zanamivir—Haemorrhage—Epirubicin—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Zanamivir—Diarrhoea—Fluorouracil—pancreatic cancer	0.00163	0.00163	CcSEcCtD
Zanamivir—Vomiting—Irinotecan—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Zanamivir—Sinusitis—Doxorubicin—pancreatic cancer	0.00158	0.00158	CcSEcCtD
Zanamivir—Dizziness—Fluorouracil—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Zanamivir—Rash—Irinotecan—pancreatic cancer	0.00157	0.00157	CcSEcCtD
Zanamivir—Dermatitis—Irinotecan—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Zanamivir—Headache—Irinotecan—pancreatic cancer	0.00156	0.00156	CcSEcCtD
Zanamivir—Erythema multiforme—Epirubicin—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Zanamivir—Vomiting—Gemcitabine—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Zanamivir—Dyspnoea—Docetaxel—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Zanamivir—Rash—Gemcitabine—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Zanamivir—Dermatitis—Gemcitabine—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Zanamivir—Haemoglobin—Doxorubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Zanamivir—Headache—Gemcitabine—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Zanamivir—Vomiting—Fluorouracil—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Zanamivir—Haemorrhage—Doxorubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Zanamivir—Rash—Fluorouracil—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Zanamivir—Dermatitis—Fluorouracil—pancreatic cancer	0.0015	0.0015	CcSEcCtD
Zanamivir—Decreased appetite—Docetaxel—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Zanamivir—Headache—Fluorouracil—pancreatic cancer	0.00149	0.00149	CcSEcCtD
Zanamivir—Fatigue—Docetaxel—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Zanamivir—Nausea—Irinotecan—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Zanamivir—Pain—Docetaxel—pancreatic cancer	0.00147	0.00147	CcSEcCtD
Zanamivir—Chills—Epirubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Zanamivir—Arrhythmia—Epirubicin—pancreatic cancer	0.00146	0.00146	CcSEcCtD
Zanamivir—Nausea—Gemcitabine—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Zanamivir—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00143	0.00143	CcSEcCtD
Zanamivir—Feeling abnormal—Docetaxel—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Nausea—Fluorouracil—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Zanamivir—Abdominal pain—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Body temperature increased—Docetaxel—pancreatic cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Chills—Doxorubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Zanamivir—Arrhythmia—Doxorubicin—pancreatic cancer	0.00135	0.00135	CcSEcCtD
Zanamivir—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00132	0.00132	CcSEcCtD
Zanamivir—Agitation—Epirubicin—pancreatic cancer	0.0013	0.0013	CcSEcCtD
Zanamivir—Malaise—Epirubicin—pancreatic cancer	0.00128	0.00128	CcSEcCtD
Zanamivir—Syncope—Epirubicin—pancreatic cancer	0.00127	0.00127	CcSEcCtD
Zanamivir—Hypersensitivity—Docetaxel—pancreatic cancer	0.00126	0.00126	CcSEcCtD
Zanamivir—Loss of consciousness—Epirubicin—pancreatic cancer	0.00125	0.00125	CcSEcCtD
Zanamivir—Cough—Epirubicin—pancreatic cancer	0.00124	0.00124	CcSEcCtD
Zanamivir—Asthenia—Docetaxel—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Zanamivir—Convulsion—Epirubicin—pancreatic cancer	0.00123	0.00123	CcSEcCtD
Zanamivir—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00122	0.00122	CcSEcCtD
Zanamivir—Myalgia—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Zanamivir—Arthralgia—Epirubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Zanamivir—Agitation—Doxorubicin—pancreatic cancer	0.00121	0.00121	CcSEcCtD
Zanamivir—Anxiety—Epirubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.0012	0.0012	CcSEcCtD
Zanamivir—Discomfort—Epirubicin—pancreatic cancer	0.00119	0.00119	CcSEcCtD
Zanamivir—Malaise—Doxorubicin—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Zanamivir—Syncope—Doxorubicin—pancreatic cancer	0.00118	0.00118	CcSEcCtD
Zanamivir—Diarrhoea—Docetaxel—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Zanamivir—Confusional state—Epirubicin—pancreatic cancer	0.00117	0.00117	CcSEcCtD
Zanamivir—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00116	0.00116	CcSEcCtD
Zanamivir—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Zanamivir—Infection—Epirubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Zanamivir—Cough—Doxorubicin—pancreatic cancer	0.00115	0.00115	CcSEcCtD
Zanamivir—Shock—Epirubicin—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Zanamivir—Convulsion—Doxorubicin—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Zanamivir—Dizziness—Docetaxel—pancreatic cancer	0.00114	0.00114	CcSEcCtD
Zanamivir—Skin disorder—Epirubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Zanamivir—Myalgia—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Zanamivir—Arthralgia—Doxorubicin—pancreatic cancer	0.00112	0.00112	CcSEcCtD
Zanamivir—Anxiety—Doxorubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00111	0.00111	CcSEcCtD
Zanamivir—Discomfort—Doxorubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Zanamivir—Anorexia—Epirubicin—pancreatic cancer	0.0011	0.0011	CcSEcCtD
Zanamivir—Vomiting—Docetaxel—pancreatic cancer	0.00109	0.00109	CcSEcCtD
Zanamivir—Rash—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Dermatitis—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Confusional state—Doxorubicin—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Headache—Docetaxel—pancreatic cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00107	0.00107	CcSEcCtD
Zanamivir—Infection—Doxorubicin—pancreatic cancer	0.00106	0.00106	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Zanamivir—Shock—Doxorubicin—pancreatic cancer	0.00105	0.00105	CcSEcCtD
Zanamivir—Skin disorder—Doxorubicin—pancreatic cancer	0.00104	0.00104	CcSEcCtD
Zanamivir—Dyspnoea—Epirubicin—pancreatic cancer	0.00103	0.00103	CcSEcCtD
Zanamivir—Anorexia—Doxorubicin—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Zanamivir—Nausea—Docetaxel—pancreatic cancer	0.00102	0.00102	CcSEcCtD
Zanamivir—Decreased appetite—Epirubicin—pancreatic cancer	0.00101	0.00101	CcSEcCtD
Zanamivir—Fatigue—Epirubicin—pancreatic cancer	0.000998	0.000998	CcSEcCtD
Zanamivir—Pain—Epirubicin—pancreatic cancer	0.00099	0.00099	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000976	0.000976	CcSEcCtD
Zanamivir—Dyspnoea—Doxorubicin—pancreatic cancer	0.000955	0.000955	CcSEcCtD
Zanamivir—Feeling abnormal—Epirubicin—pancreatic cancer	0.000954	0.000954	CcSEcCtD
Zanamivir—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000947	0.000947	CcSEcCtD
Zanamivir—Decreased appetite—Doxorubicin—pancreatic cancer	0.000931	0.000931	CcSEcCtD
Zanamivir—Fatigue—Doxorubicin—pancreatic cancer	0.000924	0.000924	CcSEcCtD
Zanamivir—Urticaria—Epirubicin—pancreatic cancer	0.00092	0.00092	CcSEcCtD
Zanamivir—Pain—Doxorubicin—pancreatic cancer	0.000916	0.000916	CcSEcCtD
Zanamivir—Abdominal pain—Epirubicin—pancreatic cancer	0.000915	0.000915	CcSEcCtD
Zanamivir—Body temperature increased—Epirubicin—pancreatic cancer	0.000915	0.000915	CcSEcCtD
Zanamivir—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000883	0.000883	CcSEcCtD
Zanamivir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000876	0.000876	CcSEcCtD
Zanamivir—Hypersensitivity—Epirubicin—pancreatic cancer	0.000853	0.000853	CcSEcCtD
Zanamivir—Urticaria—Doxorubicin—pancreatic cancer	0.000851	0.000851	CcSEcCtD
Zanamivir—Abdominal pain—Doxorubicin—pancreatic cancer	0.000847	0.000847	CcSEcCtD
Zanamivir—Body temperature increased—Doxorubicin—pancreatic cancer	0.000847	0.000847	CcSEcCtD
Zanamivir—Asthenia—Epirubicin—pancreatic cancer	0.000831	0.000831	CcSEcCtD
Zanamivir—Diarrhoea—Epirubicin—pancreatic cancer	0.000792	0.000792	CcSEcCtD
Zanamivir—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000789	0.000789	CcSEcCtD
Zanamivir—Asthenia—Doxorubicin—pancreatic cancer	0.000769	0.000769	CcSEcCtD
Zanamivir—Dizziness—Epirubicin—pancreatic cancer	0.000766	0.000766	CcSEcCtD
Zanamivir—Vomiting—Epirubicin—pancreatic cancer	0.000736	0.000736	CcSEcCtD
Zanamivir—Diarrhoea—Doxorubicin—pancreatic cancer	0.000733	0.000733	CcSEcCtD
Zanamivir—Rash—Epirubicin—pancreatic cancer	0.00073	0.00073	CcSEcCtD
Zanamivir—Dermatitis—Epirubicin—pancreatic cancer	0.000729	0.000729	CcSEcCtD
Zanamivir—Headache—Epirubicin—pancreatic cancer	0.000725	0.000725	CcSEcCtD
Zanamivir—Dizziness—Doxorubicin—pancreatic cancer	0.000708	0.000708	CcSEcCtD
Zanamivir—Nausea—Epirubicin—pancreatic cancer	0.000688	0.000688	CcSEcCtD
Zanamivir—Vomiting—Doxorubicin—pancreatic cancer	0.000681	0.000681	CcSEcCtD
Zanamivir—Rash—Doxorubicin—pancreatic cancer	0.000675	0.000675	CcSEcCtD
Zanamivir—Dermatitis—Doxorubicin—pancreatic cancer	0.000675	0.000675	CcSEcCtD
Zanamivir—Headache—Doxorubicin—pancreatic cancer	0.000671	0.000671	CcSEcCtD
Zanamivir—Nausea—Doxorubicin—pancreatic cancer	0.000636	0.000636	CcSEcCtD
